Resistance of clinically important yeasts to antifungal agents

International Journal of Antimicrobial Agents

Volumn 6, Issue 3, 1996, Pages 145-147

  Odds, Frank C ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Azoles; Candida; Resistance

Indexed keywords

ANTIFUNGAL AGENT; CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PYRROLE DERIVATIVE; STEROL DEMETHYLASE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; CANDIDA; CANDIDA ALBICANS; CONFERENCE PAPER; DRUG MECHANISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; YEAST;

EID: 0029868451     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-8579(95)00048-8     Document Type: Conference Paper

References (22)

1. Dick JD, Merz WG, Saral R. Incidence of polyene resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother 1980;18:158-163.
2. Scholer HJ. Flucytosine. In: Speller DCE (ed) Antifungal Chemotherapy. Wiley, Chichester, UK, 1980, pp. 35-106.
3. Whelan WL. The genetic basis of resistance to 5-fluorocytosine in Candida species and Cryptococcus neoformans. CRC Crit Rev Microbiol 1987;15:45-56.
4. Odds FC. Resistance of yeasts to azole-derivative antifungals. J Antimicrob Chemother 1993;31:463-471.
5. Vanden Bossche H, Marichal P, Odds FC. Molecular mechanisms of drug resistance in fungi. Trends Microbiol 1994;2:393-400.
6. Dupont B. Resistance trends in oral Candida infections: the clinical challenge. Clinician 1993;11:19-22.
7. Cameron ML, Schell WA, Bruch S, Bartlett JA, Waskin HA, Perfect JR. Correlation of in-vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob Agents Chemother 1993;37:2449-2453.
8. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. Antimicrob Agents Chemother 1994;32:2092-2098.
9. Baily GG, Perry FM, Denning DW, Mandai BK. Fluconazole-resistant candidosis in an HIV cohort. AIDS 1994;8:787-792.
10. Willocks L, Leen CLS, Brettle RP, Urquhart D, Russell TB, Milne LJR. Fluconazole resistance in AIDS patients. J Antimicrob Chemother 1991;28:937-939.
11. Fox R, Neal KR, Leen CLS, Ellis ME, Mandal BK. Fluconazole resistant Candida in AIDS. J Infect 1991;22:201-204.
12. Denning DW, Ng TTC. Fluconazole-insensitive OPC in AIDS patients. J Infect 1994;28:223-232.
13. Galgiani JN, Bartlett MS, Espinel-Ingroff A, Fromtling RA, Pfaller MA, Rinaldi MG. Reference method for broth dilution antifungal susceptibility testing of yeasts; proposed standard. NCCLS Publ M27-P, NCCLS, Villanova, PA, 1992.
14. Barchiesi F, Colombo AL, McGough DA, Fothergill AW, Rinaldi MG. In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1994;38:1530-1533.
15. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. Antimicrob Agents Chemother 1994;32:2092-2098.
16. Ben-Yaacov R, Knoller S, Caldwell GA, Becker JM, Koltin Y. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob Agents Chemother 1994;38:648-652.
17. Parkinson T, Falconer DJ, Hitchcock CA. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob Agents Chemother 1995;39:1696-1699.
18. Prasad R, Dewer-Gifosse P, Goffeau A, Balzi E. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 1995;27:320-329.
19. Vanden Bossche H, Marichal P, Odds FC, Le Jeune L, Coene M-C. Characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 1992;36:2602-2610.
20. Bart-Delabesse E, Boiron P, Carlotti A, Dupont B. Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. J Clin Microbiol 1993;31:2933-2937.
21. Pfaller MA, Rhine-Chalberg J, Redding SW et al. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 1994;32:59-94.
22. Vuffray A, Durussel C, Boerlin P et al. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients. AIDS 1994;8:708-709.